Serum Aminotransferases in Thai Children With Dengue Infection

Olarn Prommalikit1, Usa Thisyakorn2, Chule Thisyakorn2

  • 1Department of Pediatrics, Faculty of Medicine, Srinakharinwirot University, Nakhon-Nayok, Thailand.

Insights

Elevated liver enzymes, particularly aspartate aminotransferase (AST), are common in children with dengue infection. Dengue shock syndrome is associated with significantly higher AST and alanine aminotransferase (ALT) levels.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Hepatology

Background:

  • Hepatic manifestations are uncommon but recognized complications of dengue infection.
  • Understanding these liver abnormalities is crucial for managing dengue patients.

Purpose of the Study:

  • To investigate the pattern and sequential changes of serum aminotransferases (AST and ALT) in Thai children diagnosed with dengue infection.
  • To compare these liver enzyme levels between children with and without dengue shock syndrome.

Main Methods:

  • A prospective study enrolled 127 Thai children with dengue infection.
  • Patients were categorized into non-shock and shock groups.
  • Serum AST and ALT levels were measured from fever onset and up to 3 days post-shock, analyzed using Student t-test and boxplots.

Main Results:

  • Abnormal AST and ALT levels were prevalent in both groups (97.4% AST, 50.0% ALT in shock; 91.8% AST, 44.9% ALT in non-shock).
  • Significantly higher aminotransferase levels were observed in the shock group compared to the non-shock group.
  • AST levels showed a trend of increase from one day pre-shock, while ALT levels were less affected.

Conclusions:

  • Elevated serum aminotransferases are a frequent finding in pediatric dengue.
  • Aspartate aminotransferase (AST) levels are generally higher than alanine aminotransferase (ALT) in dengue patients.
  • Dengue shock syndrome is linked to significantly elevated aminotransferase levels, with AST increasing up to 3 days post-shock.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
256
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
611
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330